Introduction
Initial host defense against infections by extracellular bacteria is mediated by the innate immune response, which is characterized by the use of germline-encoded PRR that bind distinct PAMP on microorganisms. The major PRR in mammalian species are the TLR family of proteins [1] . Currently, 12 TLR are described in the mouse. TLR mediate the activation of nuclear transcription factors via one or more adaptor proteins, most critically MyD88. The ultimate result of TLR signaling is transcriptional activation of numerous genes, including those encoding various proinflammatory cytokines, chemokines, and immune receptors. A major component of innate immune activation that serves as a link to the subsequent adaptive response is the stimulation of DC that have internalized microorganisms at the site of infection [2] . Activated DC migrate to secondary lymphoid organs, undergo phenotypic maturation, present peptide/MHC, and secrete cytokines that promote T-cell activation and differentiation [3] . In this manner, the innate immune system plays a major role in initiating and guiding the adaptive immune response.
Streptococcus pneumoniae (Pn), a Gram-positive extracellular bacteria, is the most important etiological agent of communityacquired pneumonia and a major cause of morbidity and mortality in humans [4, 5] . Pn is known to contain ligands for TLR2, TLR4, and TLR9 that can act collectively to initiate innate immunity. This is largely mediated through phagocytosis and intracellular killing by neutrophils and macrophages, which are recruited to, and activated at, the site of infection [6] . Pn also elicits antibody specific for various structures on the bacterial surface, which includes the pneumococcal capsular polysaccharide (PPS) [7] , the cell wall C-polysaccharide (teichoic acid), including its phosphorylcholine (PC) moieties [8] and various pneumococcal proteins including pneumococcal surface protein (PspA) [9] . Adaptive immunity to pneumococcus is largely conferred by these antibodies, which synergize with the innate immune system to confer markedly enhanced host protection [10] .
Mice genetically deficient in TLR2 (TLR2
À/À
) exhibit an increased [11] [12] [13] , or no apparent change in [14, 15] , sensitivity to infection with Pn, depending on the model system, in contrast to the more severe defect in host defense observed in MyD88 À/À mice [15] [16] [17] . In particular, we previously demonstrated that spleen cells from TLR2 À/À mice elicit a largely normal cytokine and chemokine response in vitro and in vivo in response to Pn capsular type 14 (Pn14), associated with no increase in lethality upon i.p. infection, relative to WT mice [15] . More recently, we demonstrated that TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Pn14 [18] . In contrast to their largely intact innate response to Pn14, TLR2 À/À mice exhibited a significant decrease in the elicitation of type 1 IgG isotypes (IgG3, IgG2b, and IgG2a) specific for PPS, PC and a number of Pn proteins, whereas induced serum titers of specific IgG1 were equivalent to that observed in WT mice. Thus, the defective type 1 humoral immune response to Pn in TLR2 À/À mice suggested that TLR2 might be playing an important role directly at the level of the adaptive immune system. We previously demonstrated that the IgG, but not IgM, anti-PC, and anti-PPS14 response to immunization with heat-inactivated Pn14, was dependent on CD4 1 T cells, similar to that observed for the IgG response specific for several pneumococcal proteins [19] [20] [21] . Although TLR have been shown to be critical in mediating innate immune cell activation, they are also expressed by cells participating directly in adaptive immunity (i.e. B cells [22] , CD4 1 T cells [23] , and DC [24] ) and could therefore possibly play a more direct role in an adaptive immune response. Indeed, two recent reports have indicated a critical role for B-cell expression of MyD88 and TLR4 [25] , or TLR9 [26] We previously demonstrated that BMDC pulsed with Pn14 in vitro secrete cytokines and undergo phenotypic maturation [28] . Upon adoptive transfer into naïve WT mice, in vitro Pn14-pulsed BMDC elicit both anti-polysaccharide (including anti-PC) and antiprotein responses. The absolute requirement for viable BMDC immediately prior to injection and for BMDC that are IL-6
indicated that the transferred BMDC itself was playing an active role in this system, and not simply transferring antigen in a passive manner. We thus utilized this approach to determine the relative ability of in vitro Pn14-pulsed BMDC lacking TLR2 to elicit an IgM and IgG3 anti-PC response upon adoptive transfer into naïve WT recipients. As illustrated in Fig. 2A , Pam3Cys, a TLR2 ligand [29] , failed to induce TLR2 À/À BMDC to secrete IL-6, IL-12, and TNF-a, relative to TLR2 À/À BMDC cultured in medium alone, whereas it induced all three cytokines in WT BMDC. In contrast, cytokine secretion by TLR2 À/À BMDC in response to LPS (TLR4 ligand) [30] or CpG-ODN (TLR9 ligand) [31] was largely equivalent to WT BMDC. These data thus confirmed that BMDC obtained from mice genotyped as TLR2 À/À were indeed specifically deficient in TLR2 function. TLR2 À/À BMDC cultured with varying doses of heat-killed Pn14 in vitro were found to have a significant, though partial, defect in IL-6, IL-12, and TNF-a secretion, more apparent at lower Pn14 doses (Fig. 2B ). In contrast, there were no significant differences in type 1 IFN secretion between WT and TLR2 À/À BMDC (Fig. 2C) Pn14 was found to be essentially equivalent (Fig. 2D) . Thus, Pn14 induced, in WT and TLR2 À/À BMDC, the surface expression of MHC-II, CD80, CD86, and CD40, molecules known to play an inductive role in APC-T-cell interactions, to a similar degree. Pn14-pulsed WT and TLR2 À/À BMDC were then adoptively transferred into naïve WT mice. No significant differences between WT and TLR2 À/À BMDC in their capacity to induce an IgM or IgG3 anti-PC response were observed (Fig. 3) . Collectively, these data suggest that the defective type 1 IgG response in Ig crosslinking, synergize with several distinct TLR ligands for proliferation [34] . We thus wished to determine whether Pn14 itself was directly co-mitogenic for ad-dex-activated B cells. 
CD4
1 T-cell priming for IFN-k secretion in response to Pn14 in vivo is similar in WT and TLR2 À/À mice Since IFN-g can stimulate switching to IgG2a [35] and IgG3 [36] and is a hallmark of a type 1 cytokine response, we next wished to determine whether Pn14-primed TLR2 À/À mice exhibited diminished CD4 1 T-cell priming for IFN-g. As illustrated in Fig. 5 , spleen cells from Pn14-primed WT and TLR2 À/À mice exhibited no significant differences in CD4 1 T-cell priming for IFN-g secretion. Neither Pn14-primed WT nor TLR2 À/À mice exhibit any detectable priming for IL-4, IL-5, or IL-13 (data not shown).
B-cell and CD4 1 T-cell expression of TLR2 is critical for stimulating an optimal TD IgG3, but not TI IgM, anti-PC response to Pn14
Our in vitro mitogenesis studies ( immunized with Pn14 (Fig. 1) anti-PC response relative to that observed in mice to which no CD4 1 T cells were injected (Fig. 6B) . The data obtained on day 14 were similar to those observed on day 7 (data not shown). Collectively, these data indicate an important role for both B-cell and CD4 1 T-cell expressions of TLR2 in stimulating a primary humoral immune response to Pn14, in the setting of a largely intact innate immune system.
Discussion
In this report we investigated the mechanism underlying the defective TD type 1 IgG response to Pn14 in TLR2 À/À mice.
Although the initial innate immune response to a pathogen is known to play a major role in guiding CD4 1 T-cell subset differentiation [3] , we were intrigued by our earlier finding that the in vitro and in vivo splenic cytokine and chemokine response of TLR2 À/À mice, including IL-12 secretion, upon Pn14 challenge was largely equivalent to WT mice [15] . In addition, TLR2 À/À mice exhibited no apparent increased susceptibility to i.p. challenge with live Pn14. In light of the relatively high and easily detectable IgM and IgG3 anti-PC responses to Pn14 in WT mice, and the selective decrease in IgG3 anti-PC serum titers in Pn14-immunized TLR2
À/À mice, we studied this response in more detail to determine whether TLR2 acted directly at the level of the adaptive immune system. Although the IgM anti-PC response is T-cell-independent, an optimal IgG3 anti-PC response requires CD4 1 T-cell help [19] . Previous studies suggest that the induction of type 1 IgG responses might result from direct TLR-mediated B-cell activation, in the absence of concomitant alterations in Th1 differentiation, as illustrated in this study. Thus, CpG-ODN, a TLR9 ligand [31] , directly induces murine B cells to express germline C H transcripts specific for IgG3, IgG2b, and IgG2a, and switching to these isotypes [43] . Similarly, CpG-ODN stimulates human B cells to express C H g1, C H g2, and C H g3 germline transcripts and switch recombination, associated with an increase in activationinduced cytidine deaminase [44] , an enzyme critical for promoting switch recombination [45] . Membrane Ig crosslinking further elicited IgG production in CpG-ODN-activated human B cells. LPS, a TLR4 ligand, selectively induces class switching to IgG3 and IgG2b in murine B cells, although human papillomavirus-like particles, also signaling via TLR4, induce switching to IgG of all isotypes [46] . Stimulation of murine CD40-activated B cells via TLR7, utilizing R837, also selectively induces IgG2a/c secretion, which is further upregulated by type 1 IFN [47] .
Murine B cells can be directly co-stimulated by a number of distinct TLR2 ligands, such as lipoprotein [48] , Neisserial porins [49, 50] , and macrophage-activating lipopeptide-2 [51] to proliferate and differentiate into Ig-secreting cells. Lipoteichoic acid, which is expressed within the cell membrane of Pn, is known to bind and signal mammalian cells via TLR2 [52] . Pn also expresses lipoproteins such as pneumococcal surface adhesin A [53] , which could potentially engage TLR2 as well. However, whether direct TLR2-mediated signaling in B cells selectively induces type 1 IgG isotype expression is unknown. We further speculate that the relative inability of TLR2 À/À CD4 1 T cells to deliver help for the IgG3 anti-PC response perhaps reflects deficient T-cell-mediated stimulation of B-cell proliferation. In this regard, a requirement for a minimal number of rounds of B-cell proliferation for induction of the Ig class switch, depending on the isotype, has been demonstrated [54] . Our data are consistent with two recent reports utilizing model protein antigens [25] or VLP [26] . Thus, B-cell-deficient (mMT) mice were immunized with human serum albumin (HSA) conjugated to LPS to induce HSA-specific memory Th cells [25] . [25] . These data are analogous to ours in which B-cell TLR2 expression was critical for the TD IgG3, but not TI IgM anti-PC response to Pn14. In another recent study, WT and TLR9 À/À B cells were transferred into mMT mice and immunized with VLP loaded with CpG-ODN [26] . The IgG2a, although not IgG1, anti-VLP response in mice receiving TLR9
À/À B cells was significantly reduced relative to mice in which WT B cells were transferred. Of note, CpG-ODN is a type 1 adjuvant [55] , likely accounting for the selective change in IgG2a. Our data are the first to implicate TLR2, and to utilize an intact bacterial pathogen, to confirm and significantly extend the concept of a key role for B-cell expression of TLR in humoral immune responses. These data, to our knowledge, are also the first to implicate a role for any TLR expressed by CD4 1 T cells in mediating an in vivo primary Ig response.
Materials and methods
Mice C57BL/6, B6129SF2/J, and RAG2 À/À (C57BL/6 background) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Athymic nude mice (C57BL/6 background) were obtained from the National Cancer Institute (Frederick, MD 
Reagents
Dextran-conjugated anti-IgD (ad-dex) was prepared by conjugation of a ''b'' allotype-specific anti-IgD mAb (clone AF3) to dextran (2 Â 10 6 MW) [57] . PC-keyhole limpet hemocyanin (KLH) was synthesized as described previously [19] . Pn14 was prepared and stored as previously described [58] . Mice were immunized i.p. with 2 Â 10 8 CFU of heat-killed bacteria in 250 mL of PBS. Serum samples for measurement of anti-PC Ab titers were prepared from blood obtained through the tail vein.
Purification of splenic B and CD4 1 T cells
Single cell suspensions from spleen were prepared, and RBC were lysed using ACK lysing buffer (Quality Biological, Gaithersburg, MD). B cells were positively selected by magnetic bead sorting using anti-mouse CD45R (B220) micro magnetic beads (Miltenyi Biotec, Auburn, CA) according to the manufacturer's instructions. Cell purities were checked by flow cytometry following each purification using a BD-LSR-II flow cytometer (BD Biosciences, San Jose, CA) and found to be 90-92% B220 Production and culture of BMDC BMDC were prepared as previously described [28] . Briefly, BM cells were cultured at 1.25 Â 10 6 cells/mL (24-well plates) in a cell culture medium supplemented with 10 ng/mL murine rGM-CSF (Sigma, St. Louis, MO). After 6-8 days of culture, nonadherent cells were harvested and were found to be 90% CD11c 1 cells by flow cytometry.
Adoptive transfer of Pn14-pulsed BMDC
The method of Pn14-pulsed BMDC transfer into naïve mice has been described in detailed elsewhere [28] . Briefly, BMDC at 1 Â 10 6 /mL were incubated for 5 h in vitro with 8 Â 10 8 CFU equivalents of heat-killed Pn14. Free bacteria was then removed from the BMDC cultures by washing $6 Â in cold PBS. Pn14-pulsed BMDC were then resuspended in fresh medium at 1 Â 10 6 BMDC/200mL, and 200 mL were injected i.v. into each mouse. The concentrations of specific cytokines released into the medium of cell cultures were measured using optimized standard sandwich ELISA. Recombinant cytokines used as standards, as well as the capture mAb, biotinylated mAb used for detection, and streptavidin-alkaline phosphatase, were purchased from BD PharMingen. Streptavidin-alkaline phosphatase was used in combination with p-nitrophenyl phosphate disodium (Sigma) as a substrate to detect the specific binding. Standards were included in every plate, and the samples were tested in duplicate.
Measurement of type 1 interferon
Type 1 interferon concentrations in culture SN were measured as previously described [60] . Briefly, L cells were cultured with SN from Pn-activated BMDC cultures. L cell culture SN was then removed and cells were challenged with 100 mL encephalomyocarditis virus at 10 À3 dilution (multiplicity of infection of 0.1). Cultures were incubated overnight at 371C until the viral cytopathic effect reached 100% in mediumonly control. The process was terminated with 20% formaldehyde and the monolayer was stained with 0.5% crystal violet to detect attached, viable cells. Plates were air dried and read in a plate reader equipped with a 540 nm filter. The reciprocal dilution of the well, which exhibited a $50% cytopathic effect, was defined as the antiviral titer. All titers were compared with a reference type 1 IFN and converted to international units/mL (IU/mL).
Flow cytometric analysis
All steps were performed on ice. FcgR receptors were initially blocked by addition of 10 mg/mL of rat IgG2b,k anti-mouse FcgRI/II/III (clone 2.4G2). Cells were then stained 20 min later by incubation for an additional 30 min with PE-Armenian hamster IgG1,l2 anti-mouse CD11c (clone HL3) plus either FITC-mouse IgG2a,k anti-mouse MHC-II b (clone AF6 120.1), FITC-rat IgG2a,k anti-mouse CD40 (clone 3/23), PE-rat IgG2a,k anti-mouse CD86 (clone GL1), or Armenian hamster IgG2a,k anti-mouse (clone 16-10A1). All mAb were purchased from BD Pharmingen. Irrelevant isotype-and species-matched mAb were used as staining controls. Cells were analyzed on an EPICS XL-MCL (Beckman Coulter, Miami, FL). Dead cells and debris were eliminated from analysis by excluding cells positive for propidium iodide and gating on the appropriate forward and side scatter profile.
Measurement of serum IgM and IgG3 anti-PC titers
This assay has been previously described [58] . Briefly, Immulon 4 ELISA plates (Dynex Technologies, Chantilly, VA) were coated with PC-KLH and incubated with 3-fold dilutions of serum samples, starting at a 1/100 serum dilution. Alkaline phosphatase-conjugated polyclonal goat anti-mouse IgM or IgG3 Ab were then added, followed by addition of substrate (p-nitrophenyl phosphate, disodium; Sigma). Color was read at an absorbance of 405 nm on a Multiskan Ascent ELISA reader (Labsystems, Finland).
Statistics
Data were expressed as geometric mean7SEM of the individual results. Student's t-test was used to determine statistical significance between groups. po0.05 was considered statistically significant.
